Ken Griffin
PRPH

Ken Griffin’s ProPhase Labs PRPH Stock Holding History

Ken Griffin’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-380
Closed -$15.9K – 15009
2024
Q2 		$15.9K Sell
380
-297
-44% -$15.6K ﹤0.01% 12812
2024
Q1 		$43.8K Buy
+677
New +$34.3K ﹤0.01% 12298
2023
Q4 		– Sell
-327
Closed -$14.3K – 15021
2023
Q3 		$14.3K Buy
327
+273
+506% +$16K ﹤0.01% 12878
2023
Q2 		$3.88K Sell
54
-2,431
-98% -$198K ﹤0.01% 13648
2023
Q1 		$189K Buy
2,485
+1,396
+128% +$113K ﹤0.01% 10274
2022
Q4 		$105K Buy
+1,089
New +$118K ﹤0.01% 11149
2022
Q2 		– Sell
-1,793
Closed -$158K – 13837
2022
Q1 		$125K Sell
1,793
-1,052
-37% -$73.1K ﹤0.01% 12048
2021
Q4 		$204K Buy
2,845
+669
+31% +$41.6K ﹤0.01% 11806
2021
Q3 		$113K Buy
2,176
+590
+37% +$35.1K ﹤0.01% 12717
2021
Q2 		$98K Sell
1,586
-601
-27% -$33.8K ﹤0.01% 12934
2021
Q1 		$162K Buy
+2,187
New +$210K ﹤0.01% 11954
2019
Q2 		– Sell
-1,759
Closed -$53K – 9710
2019
Q1 		$53K Buy
+1,759
New +$54.2K ﹤0.01% 8797
2018
Q2 		– Sell
-1,155
Closed -$34K – 9185
2018
Q1 		$34K Sell
1,155
-27
-2% -$687 ﹤0.01% 8021
2017
Q4 		$26K Buy
+1,182
New +$25.8K ﹤0.01% 7793
2017
Q3 		– Sell
-1,006
Closed -$21K – 7920
2017
Q2 		$21K Buy
+1,006
New +$20.2K ﹤0.01% 7276
2017
Q1 		– Sell
-1,720
Closed -$34K – 7905
2016
Q4 		$34K Buy
+1,720
New +$34.7K ﹤0.01% 6961
2015
Q2 		– Sell
-1,527
Closed -$20K – 9003
2015
Q1 		$20K Sell
1,527
-1,206
-44% -$17.8K ﹤0.01% 7902
2014
Q4 		$39K Buy
2,733
+1,307
+92% +$18.1K ﹤0.01% 7385
2014
Q3 		$20K Buy
+1,426
New +$22.2K ﹤0.01% 7420
2014
Q1 		– Sell
-1,214
Closed -$20K – 7981
2013
Q4 		$20K Buy
+1,214
New +$21.8K ﹤0.01% 6455

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $325M AUM 19.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ken Griffin's PRPH Position: Q3 2024 in Review

Ken Griffin sold out of ProPhase Labs (PRPH) in Q3 2024, closing a stake of 380 shares — an estimated $15.9K sold.

Ken Griffin first reported a position in PRPH in Q4 2013 and held it in 20 quarters. The position peaked at $204K in Q4 2021. 27 funds tracked by Wall St. Rank hold PRPH as of Q3 2024.

  • Ken Griffin reported no remaining ProPhase Labs position as of Q3 2024 after selling out during the quarter.
  • Ken Griffin sold 380 ProPhase Labs shares in Q3 2024, an estimated $15.9K.
  • Ken Griffin first reported a position in ProPhase Labs in Q4 2013 and held it in 20 quarters.
  • Ken Griffin's ProPhase Labs position peaked at $204K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.